SCHEMBL4031117

SCHEMBL4031117

CC(C)c1oc(-c2ccc(Cl)cc2Cl)nc1CCc1noc2cc(N)ccc12

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 8/20 0.66
PPARD Q03181 8/20 0.66
PPARA Q07869 8/20 0.66
ACHE P22303 1/20 0.36
NPC1 O15118 4/20 0.36
RAB9A P51151 4/20 0.36
SMN1; SMN2 Q16637 4/20 0.36
ALDH1A1 P00352 3/20 0.36
MAPT P10636 3/20 0.36
KDM4E B2RXH2 2/20 0.36
GAA P10253 1/20 0.36
KDM1A O60341 1/20 0.36
GRM5 P41594 1/20 0.34
DPP4 P27487 1/20 0.34
DPP7 Q9UHL4 1/20 0.34
HPGD P15428 2/20 0.33
ALOX15 P16050 2/20 0.33
TP53 P04637 2/20 0.33
MAPK1 P28482 1/20 0.33
FURIN P09958 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4025100 0.89 PPARG (0.70) PPARGPPARDPPARAACHE
SCHEMBL4025444 0.87 PPARG (0.69) PPARGPPARDPPARANPC1RAB9A
SCHEMBL1765983 0.83 PPARG (0.65) PPARGPPARDPPARAACHENPC1
SCHEMBL4026750 0.83 PPARG (0.67) PPARGPPARDPPARAACHENPC1
SCHEMBL4032210 0.83 PPARG (0.72) PPARGPPARDPPARAGRM5DPP4
SCHEMBL4031523 0.82 PPARG (0.68) PPARGPPARDPPARANPC1RAB9A
SCHEMBL24658289 0.78 PPARA (0.79) PPARGPPARDPPARA
SCHEMBL30003605 0.78 PPARA (0.79) PPARGPPARDPPARA
SCHEMBL4032718 0.78 PPARG (0.69) PPARGPPARDPPARASMN1; SMN2MAPT
SCHEMBL1765990 0.77 PPARA (1.00) PPARGPPARDPPARA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1445258-B1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA NIPPON CHEMIPHAR CO (JP) 2009-06-24 EP disclosed
US-7402597-B2 Activator of peroxisome proliferator-activated receptor δ NIPPON CHEMIPHAR CO., LTD (JP) 2008-07-22 US disclosed
US-20070027196-A1 Activator of peroxisome proliferator-activated receptor delta SAKUMA SHOGO 2007-02-01 US disclosed
US-7119104-B2 Activator of peroxisome proliferator-activated receptor delta NIPPON CHEMIPHAR, CO., LTD. (JP) 2006-10-10 US disclosed
US-20050096363-A1 Activator of peroxisome proliferator-activated receptor delta NIPPON CHEMIPHAR CO., LTD. (JP) 2005-05-05 US disclosed
EP-1445258-A1 ACTIVATOR FOR PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR DELTA NIPPON CHEMIPHAR CO., LTD. (JP) 2004-08-11 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070027196-A1 Activator of peroxisome proliferator-activated receptor delta PPARA, PPARG, PPARD PPARG 2/4885PPARD 3/4885PPARA 1/4885
US-20050096363-A1 Activator of peroxisome proliferator-activated receptor delta PPARA, PPARG, PPARD PPARG 2/4885PPARD 3/4885PPARA 1/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.